 |
|
|
|
 |
|
|
| Article 1 to 10 out of 13 concerning Angiotech Pharmaceuticals, Inc.
|
-
Angiotech announces director resignation
(04/17/2008)
Angiotech Pharmaceuticals, Inc. announced the resignation of Greg Peet from his position as a non-executive director of the Company. Mr. Peet has resigned to enable him to focus on his numerous business pursuits and additional board appointments. ...
-
Angiotech receives favourable decision from the European Patent Office EPO
(03/19/2007)
Angiotech Pharmaceuticals, Inc. announced a favourable decision regarding its Hunter Patent from the European Patent Office (EPO) in Munich, Germany.The EPO's Technical Board of Appeal rejected the attempt by Conor Medsystems Inc. and Sahajanand ...
-
Angiotech Pharmaceuticals to acquire Quill Medical Inc.
(05/29/2006)
Angiotech Pharmaceuticals, Inc. announced that it has entered into a definitive agreement to acquire privately held Quill Medical, Inc., a provider of specialized, minimally invasive aesthetic surgery and wound closure technology, for US $40 million ...
-
Angiotech Pharmaceuticals and Genzyme Corporation Form Collaboration to Develop Innovative Surgical Oncology Treatments
(05/11/2006)
Angiotech Pharmaceuticals, Inc. and Genzyme Corporation announced that they have entered into a strategic collaboration agreement designed to identify, develop and commercialize innovative therapies for cancer patients undergoing surgical removal of ...
-
Boston Scientific and Angiotech Win Patent Infringement Case Against Sahajanand in the Netherlands
(05/05/2006)
Boston Scientific Corporation and Angiotech Pharmaceuticals, Inc. announced that they received a favorable decision from a Dutch court in a patent dispute against Sahajanand Medical Technologies Pvt. Ltd. Boston Scientific and Angiotech alleged that ...
-
CombinatoRx and Angiotech Sign Agreement to Apply CombinatoRx's Pipeline and Technology to the Field of Interventional Medicines
(04/18/2006)
CombinatoRx, Incorporated and Angiotech Pharmaceuticals, Inc. announced a multi-year research and license agreement for the discovery, development, and potential commercialization by Angiotech of drug devices and interventional medicine products ...
-
Angiotech Pharmaceuticals Closes Acquisition of American Medical Instruments Holdings, Inc.
(03/27/2006)
Angiotech Pharmaceuticals announced that it has closed the previously announced acquisition of American Medical Instruments Holdings, Inc. (AMI), a leading independent manufacturer of specialty, single-use medical devices, for approximately US $785 ...
-
Angiotech to appeal UK judgment regarding UK patent
(02/28/2006)
Angiotech Pharmaceuticals, Inc. announced that it intends to appeal a UK trial court decision to revoke Angiotech's UK designation of its European Patent No. 0,706,376. The UK trial court ruled that Angiotech's UK Patent lacked inventive step in ...
-
CombinatoRx and Angiotech Sign Agreement to Apply CombinatoRx's Pipeline and Technology to the Field of Interventional Medicines
(02/20/2006)
CombinatoRx, Incorporated and Angiotech Pharmaceuticals, Inc. announced a multi-year research and license agreement for the discovery, development, and potential commercialization by Angiotech of drug devices and interventional medicine products ...
-
Angiotech Announces Drug Discovery And Development Agreement with CombinatoRx
(10/05/2005)
Exclusive Collaboration With Initial Focus on Peripheral Vascular, Coronary, and Orthopedic Indications
Angiotech Pharmaceuticals, Inc. announced a license and research collaboration agreement with CombinatoRx, Incorporated focused on the selection and development of novel combination pharmaceutical compounds for Angiotech's local interventional ...
|
|
|
|
|
Top